A052670 Stock Overview
Cheilbio Co., Ltd. produces and sells veterinary products for pig, cattle, chicken, aqua, and other animals in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Cheilbio Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩2,080.00 |
| 52 Week High | ₩2,605.00 |
| 52 Week Low | ₩1,131.00 |
| Beta | 0.98 |
| 11 Month Change | 0% |
| 3 Month Change | -13.15% |
| 1 Year Change | 59.39% |
| 33 Year Change | -47.01% |
| 5 Year Change | 3.61% |
| Change since IPO | 36.84% |
Recent News & Updates
Shareholder Returns
| A052670 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 0% | -1.5% | 2.4% |
| 1Y | 59.4% | 4.6% | -4.0% |
Return vs Industry: A052670 exceeded the KR Pharmaceuticals industry which returned 7.4% over the past year.
Return vs Market: A052670 exceeded the KR Market which returned 8% over the past year.
Price Volatility
| A052670 volatility | |
|---|---|
| A052670 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A052670 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine A052670's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | n/a | Gwang-Gyeong Shim | www.cheilbio.com |
Cheilbio Co., Ltd. produces and sells veterinary products for pig, cattle, chicken, aqua, and other animals in South Korea. The company is also involved in the farm disease consulting, such as differentiation of disease and detection of pathogen; development and production of ELISA diagnostic kits; and development instant rapid kits. In addition, it offers raw materials for veterinary pharmaceuticals, fermentation and feed additives ingredients, and feed additives.
Cheilbio Co., Ltd. Fundamentals Summary
| A052670 fundamental statistics | |
|---|---|
| Market cap | ₩56.18b |
| Earnings (TTM) | -₩855.58m |
| Revenue (TTM) | ₩12.71b |
4.4x
P/S Ratio-65.7x
P/E RatioIs A052670 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A052670 income statement (TTM) | |
|---|---|
| Revenue | ₩12.71b |
| Cost of Revenue | ₩10.63b |
| Gross Profit | ₩2.09b |
| Other Expenses | ₩2.94b |
| Earnings | -₩855.58m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -31.67 |
| Gross Margin | 16.40% |
| Net Profit Margin | -6.73% |
| Debt/Equity Ratio | 0% |
How did A052670 perform over the long term?
See historical performance and comparison